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Background: Geographical disparity in colorectal cancer (CRC) survival rates may be
partly due to aging populations and disadvantage in more remote locations; factors that
also impact the incidence and outcomes of other chronic health conditions. The current
study investigates whether geographic disparity exists amongst previously diagnosed
health conditions in CRC patients above and beyond age and area-level disadvantage
and whether this disparity is linked to geographic disparity in CRC survival.
Methods: Data regarding previously diagnosed health conditions were collected via
computer-assisted telephone interviews with a cross-sectional sample of n = 1,966
Australian CRC patients between 2003 and 2004. Ten-year survival outcomes were
acquired in December 2014 from cancer registry data. Multivariate logistic regressions
were applied to test associations between previously diagnosed health conditions and
survival rates in rural, regional, and metropolitan areas.
Results: Results suggest that only few geographical disparities exist in previously
diagnosed health conditions for CRC patients and these were largely explained by
socio-economic status and age. Living in an inner regional area was associated with
cardio-vascular conditions, one or more respiratory diseases, and multiple respiratory
diagnoses. Higher occurrences of these conditions did not explain lower CRC-specific
10 years survival rates in inner regional Australia.
Conclusion: It is unlikely that health disparities in terms of previously diagnosed
conditions account for poorer CRC survival in regional and remote areas. Interventions
to improve the health of regional CRC patients may need to target issues unique to
socio-economic disadvantage and older age.
Keywords: colorectal cancer, comorbidity, regional disparity, socio-economic status, rural health
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INTRODUCTION

TABLE 1 | Sample characteristics (n = 1,966).
n (%)

There is growing concern over health disparities between
rural, regional, and metropolitan communities in Australia and
internationally (1–4). Evidence suggests that individuals living
in geographically remote areas experience higher incidence of
morbidity and mortality than their metropolitan counterparts
(1, 5–7). Living in a non-metropolitan area has been associated
with higher incidences of a number of serious health conditions
including cancer (2, 6–8), diabetes, and cardiovascular disease
(9, 10). In terms of mortality, geographical remoteness is also
associated with lower chance of survival for those diagnosed with
many serious health conditions (11, 12). In particular, it has been
estimated that patients with colorectal cancer (CRC) residing
in non-metropolitan areas have between a 4 and 30% higher
chance of dying from the disease, within 5 years of diagnosis, than
metropolitan residents (13, 14).
Geographical health disparities are thought to be due, not only
to limited physical access to health care, but also to differences
in demography, attitudes, lifestyle factors, and cultural practices
in regional and rural settings (5, 6, 15). However, it is unclear
whether these factors provide a full explanation for regional
disparity in CRC outcomes. Individuals living in regional and
remote areas exhibit poorer health profiles (e.g., more likely
to experience multiple chronic conditions) than those living
in metropolitan areas (2, 7–10). Pre-existing comorbid health
conditions often lead to later CRC detection, make patients less
suitable candidates for curative surgery, and increase the chance
of mortality by approximately 20% (16–18). Given these risks, it
is plausible that geographical disparity in CRC outcomes may be
somewhat accounted for by a tendency for regional and remote
patients to report multiple health problems.
Remote and regional areas also tend to have different
demographic profiles than major cities, with higher proportions
of older residents and higher area level disadvantage (19); factors
that contribute to CRC incidence and mortality as well as
comorbidity and poorer health in general (16, 20, 21). Average
age and socio-economic status (SES) in regional and remote areas
are likely to account for geographical disparity in the diagnosis
of other health conditions among CRC patients. In order
to identify and address the causes of geographical disparities
in the health and mortality of CRC patients, it is therefore
important to establish whether these disparities exist above and
beyond age and area level disadvantage. Without this knowledge,
those working to improve outcomes for non-metropolitan CRC
patients, may concentrate efforts toward increasing healthcare
access in remote areas and fail to address the health issues
associated with socio-economic disadvantage and older age.
Understanding the risk factors associated with other
diagnosed health conditions among CRC patients is an
important focus for health researchers and policymakers
who wish to improve cancer outcomes. To date, no study
has measured comorbid (or premorbid) conditions in rural,
regional, and metropolitan CRC patients, nor has their impact on
geographical disparities in CRC survival rates been empirically
tested. The aim of this study is to determine whether geographical
disparities in previously diagnosed chronic health conditions
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SEX
Female

790 (40%)

AGE
20–49 yrs

167 (8.5%)

50–59 yrs

382 (19.4%)

60–69 yrs

665 (33.8%)

70–79 yrs

752 (38.3%)

SES QUINTILE
(lowest) 1

334 (17.0%)

2

325 (16.5%)

3

365 (18.6%)

4

651 (33.1%)

(highest) 5

288 (14.6%)

LOCATION (ASGC-RA)
Metropolitan

981 (49.9%)

Inner regional

622 (31.6%)

Outer regional

336 (17.1%)

Remote

19 (1.0%)

Very Remote

8 (0.4%)

SITE
Colon

1203 (69.9%)

Rectum

519 (30.1%)

STAGE (DUKES)
A

437 (29.4%)

B

521 (35.1%)

C

487 (32.8%)

D

40 (2.7%)

exist above and beyond the age and SES of CRC patients and
whether such disparities play a role in reduced CRC survival
rates in regional and remote areas compared to major cities.

METHODS
Participants and Procedure
Data collection for this study formed part of the Colorectal
Cancer and Quality of Life Study (for recruitment details see
(22)). Approval for the use of these data was granted by
the University’s Human Research Ethics Committee (Approval
Number: H17-REA014). Participants had a primary diagnosis
of CRC between 1 January 2003 and 31 December 2004, were
between the ages of 20 and 80 years, 59.8% male and reasonably
evenly distributed across SES deciles. The most common cancer
site was the colon (70%). Table 1 provides a breakdown of
participant demographics, cancer site, and stage information for
the current sample.
Participants were invited (n = 3,182) to the research via mail
through their treating doctor who consented to and endorsed the
invitation. Participants who responded and provided informed
consent (n = 2181) were then contacted by phone to complete a
computer assisted telephone interview (CATI), 90% (n = 1,966)
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of the respondents completed the interview comprising the
sample for the current study.
Representativeness of the sample was evaluated by comparing
gender, age, and disease specific information from the current
sample to those who were eligible, but were not recruited to the
study. There were no gender differences, however, 70–80 years
old CRC survivors were under represented along with those with
rectal and advanced stage cancer (p = < 0.05).

TABLE 2 | Descriptive statistics of sample and Zero-order correlations between
premorbid conditions, SES and age.
Bivariate correlations (r)

Mean (SD)

SES

SES

54.00 (26.26)

age

65.01 (10.35)

Any cardiovascular

Measures
Demographics
Each respondent provided their gender, date of birth, and postal
address. Participant location of residence was categorized as
major city; inner regional; outer regional; remote; or very remote
based on the Australian Standard Geographical Classification Remoteness Area (ASGC-RA; AGDHA 2006). For the purposes
of this study, major city residents were coded as (1) major city
(N = 981); (2) inner regional coded as regional (N = 622) and
the remainder coded as (3) outer regional and remote (N = 363)
as per methods used in Australian Institute of Health and Welfare
(AIHW) studies in 2008 (23). Each participant was assigned a
percentile rank based on the Socio-Economic Index for Areas
(SEIFA); which reflected their estimated socio-economic status
(SES) according to postcode; a rank of 1 indicating that the
participant resided in an area assigned the lowest SES and a rank
of 100 reflecting the highest.

Stage and 10-years Censored Mortality Data (All
Cause and CRC Specific)
The mortality status of each participant at the 30th of December
2013 was obtained from the relevant State Government
Department of Births, Deaths, and Marriages along with stage
of cancer at diagnosis. This information includes date and cause
of death and is checked against data from hospitals, nursing
homes, coroners, the National Death Index, and the Australian
Bureau of Statistics. A censored mortality variable was created
that indicated whether or not the patient had passed away by
the end of the study. Elapsed time since diagnosis was defined
as total days from patient diagnosis to death or to the end of the
study—whichever came first.

Age

1
59.4

−0.039

1

−0.033

0.284**

Heart attack

7.7

−0.070**

0.158**

9.9

−0.084**

0.174**

High blood
pressure

40.9

−0.060**

0.222**

High cholesterol

28.7

0.003

0.142**

Other heart
condition

15.6

−0.013

0.183**

4.1

0.011

0.115**

Any respiratory

17.9

0.007

0.061**

Asthma

12.7

0.021

0.024

6.2

0.003

0.035

Chronic Bronchitis

Participants were asked to identify (on a checklist—see Table 2)
any health conditions they had previously been diagnosed with1 .
Body mass index (BMI) for each participant was calculated
using their self-reported weight (prior to diagnosis) and height.
According to World Health Organization recommendations,
participants with a BMI over 30 were classified as obese.

%

Angina Pectoris

Stroke

Previously Diagnosed Conditions

Emphysema

3.6

−0.022

0.094**

Any skeletal

25.2

−0.009

0.218**

Osteoporosis

5.9

0.021

0.145**

Osteoarthritis

16.5

−0.020

0.163**

Rheumatoid
Arthritis

5.4

−0.019

0.065**

Leukemia

0.8

−0.022

0.035

Any other

62.4

−0.045*

0.020
0.118**

Diabetes

12.6

−0.027

Ulcer

12.4

0.014

Migraine

12.8

0.004

Depression

13.5

−0.010

Any previous
cancer

20.0

−0.066**

Obese

0.076**
−0.024
−0.073**
0.058*

25.5

−0.019

−0.109**

Other serious
illness

1.9

−0.002

0.054*

Any condition

87.6

−0.055*

0.224**

** < p = 0.01, *< p = 0.05.

site or system in the body which that condition effects (i.e.,
cardiovascular, respiratory, skeletal, and other conditions) and
coded participants according to whether they reported one
or more of each type of condition (see Table 2). Secondly,
we investigated multimorbidity through a clustering method
of pairwise concordance statistics (24). This method adopts
the asymmetric Somers’ D statistic to quantify the degree
of “non-random” multimorbidity, also known as “associative
multimorbidity” (25). Identification of significant (non-random)
multimorbidity between conditions is an informative way to
view disease patterns and indicates a potential sharing of risk
factors of the diseases (26, 27). The clustering method adopts
the Benjamini-Hochberg procedure to control for the false
discovery rate, offering protection against false positives (28).
The use of UCINET6 for Windows (29) can graphically display
the identified multimorbidity patterns of health conditions,

Clustering of Conditions
We employed two methods of grouping health conditions for
analytic purposes (the first intuitive and the second statistical).
Firstly, we categorized conditions according to the physical
1 With

the exception of “heart attack”, “stroke”, and “angina pectoris”, items
reflected pervasive, chronic conditions that, although likely to be comorbid with
the colorectal diagnosis, cannot be assumed as such hence we refer to as previously
diagnosed conditions, rather than comorbid conditions.
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0.46 (0.21, 0.98)
1.42 (0.99, 2.05)∧

0.46 (0.22, 0.95)
1.40 (0.99, 1.98)∧

0.53 (0.25, 1.10)

4

1.02 (0.73, 1.42)

0.75 (0.55, 1.02)∧

0.99 (0.39, 2.57)

Any previous cancer

Obese

Other serious illness
0.88 (0.58, 1.35)

0.90 (0.35, 2.34)

1.16 (0.78, 1.72)

0.95 (0.60, 1.50)

0.77 (0.50, 1.20)

0.93 (0.34, 2.53)

0.76 (0.55, 1.05)

0.84 (0.60, 1.19)

1.07 (0.71, 1.63)

1.32 (0.88, 1.98)

1.21 (0.80, 1.82)

1.06 (0.66, 1.70)

1.28 (0.44, 3.68)

1.34 (0.95, 1.89)

1.00 (0.68, 1.46)

0.69 (0.43, 1.12)

0.96 (0.61, 1.52)

1.23 (0.79, 1.91)

1.03 (0.75, 1.41)
1.18 (0.75, 1.85)

0.91 (0.68, 1.21)

1.09 (0.20, 6.03)

1.60 (0.86, 2.97)

0.73 (0.48, 1.13)

0.66 (0.43, 1.02)∧

0.47 (0.09, 2.36)

1.48 (0.83, 2.61)

1.10 (0.75, 1.60)

0.97 (0.49, 1.90)

0.96 (0.67, 1.36)

0.29 (0.09, 0.90)

0.62 (0.31, 1.26)

0.77 (0.47, 1.24)

0.60 (0.39, 0.92)

1.40 (0.66, 2.96)

0.78 (0.50, 2.18)

1.19 (0.85, 1.66)

1.16 (0.85, 1.58)

0.61 (0.34, 1.07)

0.75 (0.41, 1.37)

0.96 (0.72, 1.32)

Contrast variable coding: a Metro = −0.5, Regional = 0.5, Rural = 0.
b Metro = −0.5, Regional=0, Rural = 0.5.
c Metro = 0, Regional = −0.5, Rural = 0.5; bold = significant at p < 0.05; ∧ = marginally significant, p < 0.075.

1.06 (0.70, 1.59)

0.79 (0.58, 1.08)

1.09 (0.74, 1.63)

Depression

Any condition

0.98 (0.71, 1.37)

1.23 (084, 1.82)

Migraine headaches

1.08 (0.73, 1.59)

1.14 (0.77, 1.68)

Stomach ulcer

0.73 (0.48, 1.10)

0.80 (0.53, 1.20)

0.99 (0.76, 1.31)

0.61 (0.13, 2.97)

1.39 (0.81, 2.39)

1.15 (0.80, 1.66)

0.56 (0.30, 1.07)

Diabetes

1.00 (0.76, 1.32)

0.67 (0.14, 3.25)

Any other

1.39 (0.81, 2.39)

Leukemia

1.28 (0.90, 1.83)

Osteoarthritis

Rheumatoid arthritis

0.65 (0.35, 1.20)

Osteoporosis

0.55 (0.30, 1.03)∧

1.91 (0.85, 4.25)
1.02 (0.74, 1.42)

1.02 (0.74, 1.39)

2.11 (0.97, 4.58)∧

1.16 (0.85, 1.56)

2.37 (1.09, 5.12)

Emphysema

Any skeletal

1.31 (0.86, 1.98)
1.71 (0.96, 3.03)∧

1.22 (0.82, 1.82)
1.62 (0.94, 2.80)

1.24 (0.83, 1.84)

1.68(0.97, 2.89)∧

Chronic Bronchitis

1.40 (0.96, 2.05)

0.75 (0.55, 1.03)

0.75 (0.56, 1.02)∧

Asthma

Any respiratory

1.45 (1.03, 2.06)

1.53 (1.07, 2.18)

Other heart condition

Stroke

1.36 (0.95, 1.96)

0.82 (0.61, 1.10)

High cholesterol

0.81 (0.60, 1.08)

0.88 (0.67, 1.17)

0.89 (0.55, 1.44)

1.00 (0.76, 1.30)

High blood pressure

1.18 (0.75, 1.86)

1.35 (0.86, 2.11)

Angina pectoris

0.89 (0.66, 1.20)
1.34 (0.81, 2.23)

0.93 (0.70, 1.24)
1.59 (0.98, 2.59)∧

1.09 (0.83, 1.44)

1.81 (1.13, 2.92)

Heart attack

Unadjusted

1.22 (0.75, 1.98)

1.43 (0.49, 4.15)

1.28 (0.91, 1.81)

1.03 (0.70, 1.51)

0.66 (0.41, 1.07)

0.95 (0.60, 1.50)

1.31 (0.84, 2.04)

1.30 (0.83, 2.06)

1.04 (0.76, 1.43)

1.22 (0.22, 6.79)

1.60 (0.86, 2.97)

0.82 (0.53, 1.28)

1.17 (0.59, 2.32)

1.11 (0.77, 1.60)

0.34 (0.11, 1.04)∧

0.65 (0.32, 1.31)

0.78 (0.48, 1.26)

0.62 (0.40, 0.96)

1.68 (0.79, 3.59)

0.89 (0.57, 1.39)

1.30 (0.92, 1.82)

1.32 (0.96, 1.82)

0.71 (0.40, 1.26)

0.89 (0.48, 1.65)

1.11 (0.80, 1.55)

Adjustedage

Adjustedage,SES

Adjustedage

Any cardiovascular

Unadjusted

Rural vs. Metrob

Regional vs. Metroa

OR (CI, 95%)

1.11 (0.68, 1.20)

1.46 (0.50, 4.31)

1.25 (0.88, 1.77)

0.94 (0.64, 1.38)

0.63 (0.39, 1.02)

0.99 (0.98, 1.01)

1.40 (0.89, 2.21)

1.23 (0.78, 1.96)

0.98 (0.71, 1.36)

1.05 (0.19, 5.89)

1.66 (0.88, 3.11)

0.80 (0.51, 1.25)

1.18 (0.59, 2.36)

1.11 (0.77, 1.61)

0.32 (0.10, 1.00)

0.67 (0.33, 1.36)

0.82 (0.50, 1.33)

0.63 (0.40, 0.97)

1.69 (0.78, 3.63)

0.91 (0.58, 1.42)

1.30 (0.92, 1.83)

1.25 (0.90, 1.72)

0.60 (0.34, 1.08)

0.81, (0.43, 1.50)

1.09 (0.78, 1.51)

Adjustedage,SES

0.61 (0.29, 1.25)

1.39 (0.26, 7.33)

1.36 (0.79, 2.45)

1.03 (0.54, 1.96)

1.03 (0.47, 2.27)

0.67 (0.29, 1.53)

0.60 (0.26, 1.38)

1.24 (0.59, 2.63)

0.86 (0.51, 1.46)

4.61 (0.64, 33.17)

0.78 (0.26, 2.32)

0.49 (0.22, 1.11)

1.12 (0.35, 3.53)

0.76 (0.41, 1.40)

0.08 (0.01, 0.77)

0.20 (0.05, 0.86)

0.47 (0.19, 1.18)

0.32 (0.14, 0.76)

1.33 (0.38, 4.64)

0.35 (0.15, 0.83)

1.10 (0.62, 1.94)

1.04 (0.62, 1.76)

0.77 (0.29, 2.07)

0.36 (0.11, 1.06)

0.69 (0.41, 1.17)

Unadjusted

0.74 (0.34, 1.61)

1.57 (0.31, 7.99)

1.28 (0.72, 2.27)

1.09 (0.57, 2.06)

0.95 (0.43, 2.13)

0.65 (0.28, 1.49)

0.66 (0.29, 1.50)

1.41 (0.67, 2.96)

0.87 (0.51, 1.49)

5.02 (0.71, 35.40)

0.87 (0.30, 2.52)

0.59 (0.27, 1.32)

1.41, (0.46, 4.33)

0.91 (0.49, 1.70)

0.11 (0.01, 1.04)∧

0.22 (0.50, 0.92)

0.49 (0.19, 1.22)

0.35 (0.15, 0.82)

1.63 (0.48, 5.50)

0.84 (0.37, 1.89)

1.53 (0.29, 8.06)

1.34 (0.75, 2.40)

1.30 (0.69, 2.44)

1.06 (0.48, 2.35)

0.61 (0.26, 1.45)

0.55(0.23, 1.33)

1.52 (0.73, 3.20)

0.96 (0.56, 1.66)

5.61 (0.86, 36.21)∧

0.83 (0.28, 2.51)

0.63 (0.28, 1.42)

1.33 (0.42, 4.23)

0.90 (0.48, 1.69)

0.15 (0.02, 1.41)

0.19 (0.40, 0.87)

0.42 (0.16, 1.12)

0.33 (0.14, 0.81)

1.55 (0.44, 5.42)

1.21 (0.68, 2.15)
0.42 (0.18, 1.00) ∧

0.44 (0.19, 1.01)∧

1.38 (0.80, 2.39)

1.14 (0.46, 2.86)

0.65 (0.22, 1.91)

0.99 (0.53, 1.60)

Adjustedage,SES

1.24 (0.70, 2.18)

1.24 (0.73, 2.12)

1.15 (0.65, 2.04)

0.47 (0.15, 1.47)

0.83 (0.49, 1.44)

Adjustedage

Rural vs. Regionalc

TABLE 3 | Odds Ratios (and 95% Confidence Intervals) for reporting each of the listed pre-morbid health conditions for rural, regional, and metropolitan CRC patients (unadjusted and controlling for age and SES).
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other heart condition (OR = 1.53, 95% CI = 1.07–2.18), one
or more respiratory conditions (OR = 1.45, 95% CI = 1.03–
2.06), or emphysema (OR = 2.37, 95% CI = 1.09–5.12). When
adjusted for age, ORs became insignificant for other heart
conditions (OR = 1.36, 95% CI = 0.95–1.96) and marginally
significant for heart attack (OR = 1.59, 95% CI = 0.98–
2.59), one or more respiratory conditions (OR = 1.40, 95%
CI = 0.99–1.98) and emphysema (OR = 2.11, 95% CI = 0.97–
4.58). These marginally significant results remained when ORs
were adjusted for both age and SEIFA rank. In the case of
emphysema, the age and SES adjusted OR was not significant.
A suppression effect (31) of SEIFA rank was apparent in the
case of stroke (OR = 0.46, 95% CI = 0.21–0.98), whereby
adjusting the OR for SES increased significance. That is, although
previous stroke diagnosis is not associated with the variance
in location (regional vs. major city) that is shared with SES, it
is associated with the variance in location that is not shared
with SES.

where any two conditions form the “closest” pair when their
pairwise Somers’ D statistic is maximum and significant. Presence
or absence of comorbid conditions for each participant were
saved as variables for analysis. These two grouping methods
allowed us to draw conclusions regarding the likelihood of rural,
regional, and metropolitan CRC patients reporting a certain type
of condition, as well as the likelihood of reporting multiple
commonly co-occurring conditions.

Data Analysis
Contrast variables (see Table 2 notes) were created in order to
apply all three comparisons between major city, regional, and
rural groups in separate analyses. Logistic regression was applied
to estimate the odds ratio (OR) associated with each condition,
each type of condition, and multimorbidity cluster membership
across rural, regional, and major cities. Unadjusted ORs and 95%
confidence intervals were reported alongside those adjusted for
age and SES. Cox regressions were then conducted to estimate
hazard ratios (HR) and 95% confidence intervals associated with
patient location of residence, controlling for stage of cancer at
diagnosis, age, and SES. Mediations were tested through a series
of Cox regression models and Sobel tests to assess significance of
the indirect effect. All main analyses were performed in IBM SPSS
version 23 (30).

Rural vs. Major City
Rural CRC patients were significantly less likely than major city
dwellers to report a previous diagnosis of one or more respiratory
conditions (OR = 0.60, 95% CI = 0.39–0.92) or emphysema
(OR = 0.29, 95% CI = 0.09–0.90). The age and SES adjusted
ORs for respiratory conditions (OR = 0.63, 95% CI = 0.40–0.97)
and emphysema (OR = 0.32, 95% CI = 0.10–1.00) remained
significant suggesting that these factors do not account for any
of the effects of location on diagnosis. No other significant
differences in diagnoses were found between rural and major city
patients.

RESULTS
Table 2 reports the percentage of participants that reported
a previous diagnosis of each condition. The most commonly
reported condition was high blood pressure (40.9%), followed by
high cholesterol (28.7%), obesity (25.5%), and a previous cancer
diagnosis (20.0%). One or more cardiovascular-related diagnoses
were reported by 59.4% of participants, while 17.9% reported at
least one respiratory condition and 25.2% reported at least one
skeletal condition. Eighty-seven percent of the sample reported
being previously diagnosed with at least one condition overall.
Preliminary analyses of variance showed that remoteness
of living was negatively associated with SES and the patients
living in regional areas were significantly older than those in
metropolitan or rural areas. As shown in Table 2, SES was weakly,
but significantly negatively associated with a previous diagnosis
of heart attack (r = −0.07, p < 0.01), angina pectoris (r = −0.08,
p < 0.01), high blood pressure (r = −0.06, p < 0.01), one or
more other serious illness (r = −0.05, p<.05), previous cancer
diagnosis (r = −0.07, p < 0.01), and one more previously
diagnosed condition overall (r = −0.06, p < 0.05). Based on
these results, which suggest that SEIFA rank and age are related
to both remoteness and several premorbid diagnoses, crude ORs
as well as age- and SES-adjusted ORs are presented in the main
analysis.

Rural vs. Regional
Rural patients were significantly less likely to report a previous
diagnosis of other heart conditions (OR = 0.35, 95% CI = 0.15–
0.83), any respiratory disease (OR = 0.32, 95% CI = 0.14–
0.76), chronic bronchitis (OR = 0.20, 95% CI = 0.05–0.86)
and emphysema (OR = 0.08, 95% CI = 0.01–0.77) when
compared to regional patients. These effects remained significant,
or marginally significant, when ORs were adjusted for age and
SES.

TABLE 4 | Five overlapping clusters of conditions.

Main Analyses
Regional vs. Major City
As shown in Table 3, crude logistic regression results suggest
that when compared to CRC patients living in major cities,
regional CRC patients were significantly more likely to report
having had a heart attack (OR = 1.81, 95% CI = 1.13–2.92),
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Cluster label

Conditions on cluster

Strength of
multimorbidity

Cluster 1
(CVD)

Heart attack, Angina pectoris, High blood
pressure, High cholesterol, Stroke

0.250

Cluster 2
(CVD + diabetes)

Heart attack, High blood pressure, High
cholesterol, Stroke, Diabetes

0.199

Cluster 3
(Respiratory)

Asthma, Chronic bronchitis, Emphysema

0.249

Cluster 4
(HBP + diabetes +
obese)

High blood pressure, Diabetes, Obese

0.200

Cluster 5
(CVD + arthritis)

High blood pressure, High cholesterol,
Osteoarthritis

0.175
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Multimorbidity Analysis

(HR = 1.27, 95% CI = 1.09–1.47), however as shown in Figure 2,
was insignificant when adjusted for age and SES (HR = 1.08,
95% CI = 0.91–1.29). Crude comparison of metropolitan and
rural patients showed higher survival in metropolitan areas
(HR = 1.23, 95% CI = 1.03–1.47). This result did not change
when adjusted for age, but was non-significant when adjusted
for SES (HR = 1.04, 95% CI = 0.86–1.27). The same pattern of
results was found when comparing rural and regional patients
(HR = 0.63, 95% CI = 0.48–0.82, adjusted for age (HR = 0.67,
95% CI=0.51–0.88) and age and SES (HR = 0.86, 95% CI = 0.63–
1.14).
Diagnoses of other heart conditions (HR = 1.15, 95%
CI = 0.96–1.37) and any (HR = 1.01, 95% CI = 0.82–1.23) or
multiple (HR = 0.97, 95% CI = 0.66–1.42) respiratory diseases
were not related to all-cause mortality at 10 years post diagnosis.
Heart attack (HR = 1.164, 95% CI = 1.33–2.04) and emphysema
(marginally; HR = 1.43, 95% CI = 0.99–2.07) were associated
with lower 10 years survival. Heart attack diagnosis partially
mediated the relationship between regional status and all-cause
10 years survival (z = 2.14(0.11), p < 0.05).

Multimorbidity analysis identified five overlapping clusters
of conditions (see Table 4). High blood pressure and high
cholesterol showed the highest number of comorbid conditions,
followed by heart attack, angina pectoris, stroke, and diabetes (see
Figure 1). Most of the overlapping clusters related to conditions
of the same type (e.g., cardiovascular disease group: heart
attack, angina pectoris, high blood pressure, high cholesterol,
and stroke), however, there were links with diabetes as well as
osteoarthritis with the cardiovascular disease group. Further, a
respiratory cluster (asthma, chronic bronchitis, emphysema) and
a cluster associating high blood pressure, diabetes, and obesity
were identified.
As shown in Table 5, only membership in the respiratory
cluster significantly differed according to location. That is,
adjusting for age and SES, regional CRC patients were more
likely to report multiple respiratory diagnoses compared to
metropolitan patients (HR = 1.92, 95% CI = 1.05–1.3.51). Also,
rural patients were marginally less likely than regional patients
to report diagnosis of multiple respiratory disorders (HR = 0.36,
95% CI = 0.12–1.03).

Survival Analysis

DISCUSSION

No significant differences were found between CRC specific 10
years mortality2 and patient place of residence. However, when
controlling for stage of cancer at diagnosis, residing in a regional
area was associated with a higher risk of all-cause mortality
at 10 years post diagnosis when compared to metropolitan
patients (HR = 1.33, 95% CI = 1.14–1.56). This effect was
reduced slightly but remained significant when adjusted for age

The current study compared previously diagnosed health
conditions in metropolitan, regional, and rural CRC patients
and investigated whether geographical disparity existed above
and beyond the effects of age and SES. Findings suggest that
place of residence is largely unrelated to the previous diagnosis
of other serious health conditions, however, some disparities
were apparent for certain conditions, namely, cardio-vascular
and respiratory health conditions were more common in inner
regional areas. The findings also indicated that CRC patients

2 5-year mortality was also measured and no significant differences were found for
patient place of residence.

FIGURE 1 | Multimorbidity between 17 conditions (nodal size is proportional to the number of conditions comorbid with the condition; bolded lines link the “closest”
pairs).
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1.10 (0.87, 1.39)

1.06 (0.83, 1.33)

1.08 (0.85, 1.38)

1.05 (0.81, 1.37)

0.94 (0.62, 1.43)

0.95 (0.63, 1.46)

1.05 (0.59, 1.88)

1.18 (0.75, 1.87)

living in regional Australia experience lower 10-years survival
from all causes.
The regional disparity in previously diagnosed health
conditions identified here were mostly explained by older age
and lower SES in inner regional locations, suggesting that the
demographic profile of rural and regional areas play a key
role in health disparities in non-metropolitan areas. It has long
been established that low SES is associated with poorer health
(20, 32). Educational, financial, and social disadvantage can
often result in depleted resources for leading a healthy lifestyle
and addressing health issues (33–35). Our findings support
a growing body of recent evidence suggesting that regional
disparity in health may be less about location and more about
the characteristics of people within a geographic region (36–38).
Recently, health researchers have suggested a shift in focus from
broad urban-rural health disparities to understanding the unique
characteristics of different communities and the individuals
within them (36, 39, 40). To make the greatest improvements
to the health of regional populations, it is recommended that
health interventions be targeted at, and tailored toward, lower
SES individuals and communities (41, 42). The current findings
support this recommendation and suggest its application in
CRC specific contexts. Although the association between age
and mortality is unalterable, our findings raise further awareness
of the aging population of our rural and regional communities
and the need for focus on age appropriate health services and
interventions in these areas.
In the current study, regional patients were more likely
than both metropolitan and rural patients to report a previous
diagnosis of certain heart conditions, one of several respiratory
diseases, or multiple respiratory diseases. Research in general
(not CRC-specific) adult populations has yielded similar results
to those found here, highlighting that geographical disparities in
health conditions are not unique to CRC patients. For example,
AIHW data from a similar time period (2004–2005) shows that
in general, Australians living in regional areas are significantly
more likely to report various respiratory and heart problems
(23). Results also suggested that higher mortality in regional
CRC patients was partially attributed to their higher risk of heart
attack which is not surprising considering the high risk of heart
attack recurrence in any population (43). Although this finding
highlights the ill-effects of regional health disparities on survival
in general, it does not provide evidence of impact on CRC-specific
survival. Nevertheless, considering the common lifestyle factors
that lead to both cardiovascular and colorectal disease (i.e.,
diet and exercise), these findings strengthen the importance of
targeting lifestyle change for improving chronic disease outcomes
in regional areas (3, 5).
Despite previous evidence for an association between
increasing remoteness and poor health (2, 6–10), rural CRC
patients in this study (those living in the most remote areas) were
no more likely to report a previously diagnosed condition, and
were less likely to report previously diagnosed heart, or one or
multiple respiratory conditions, than metropolitan and regional
patients. This finding was unexpected considering substantial
evidence suggesting rural residents report poorer health and
shorter life expectancy than those living in major cities (6, 44).

1.17 (0.96, 1.44)
Any multimorbidity

1.12 (0.90, 1.38)

1.18 (0.75, 1.87)
0.95 (0.63, 1.46)

0.85 (0.49, 1.45)
0.83 (0.49, 1.41)

0.94 (0.62, 1.43)
1.03 (0.76, 1.42)

0.81 (0.53, 1.22)
0.96 (0.66, 1.40)

1.17 (0.88, 1.03)
1.15 (0.87, 1.54)

0.92 (0.64, 1.33)
0.91 (0.64, 1.29)

0.87 (0.66, 1.16)
1.02 (0.79, 1.31)

1.06 (0.77, 1.45)

1.04 (0.81, 1.33)

1.10 (0.80, 1.51)
Cluster 5 (CVD+arthritis)

1.59 (0.94, 2.71)
1.61∧ (0.95, 2.75)
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Cluster 4 (HBP+ diabetes+ obese)

1.44 (0.77, 2.67)

0.36∧ (0.12, 1.03)
0.47 (0.19, 1.21)
0.47 (0.18, 1.19)
1.20 (0.61, 2.36)
1.12 (0.60, 2.07)
1.11 (0.60, 2.05)

1.18 (0.76, 1.84)

Cluster 3 (Respiratory)

1.92 (1.05, 3.51)

1.23 (0.70, 2.18)

0.96 (0.64, 1.44)
0.93 (0.63, 1.38)

1.20 (0.68, 2.11)
0.94 (0.61, 1.46)

0.97 (0.71, 1.32)
1.10 (0.83, 1.45)

1.02 (0.68, 1.52)
0.98 (0.66, 1.45)

1.05 (0.80, 1.37)
0.83 (0.63, 1.9)

0.73 (0.50, 1.08)
0.83 (0.59, 1.17)
0.41 (0.61, 1.22)

0.97 (0.76, 1.23)
1.02 (0.81, 1.29)

Cluster 2 (CVD + diabetes)

Adjustedage,SES
Unadjusted

Cluster 1 (CVD)

Adjustedage,SES
Adjustedage
Adjustedage
Adjustedage

Unadjusted

Rural vs. Metrob

OR (CI, 95%)

Adjustedage,SES

Unadjusted

Rural vs. Regionalc

Geographic Disparity in CRC Health

Regional vs. Metroa

TABLE 5 | Odds Ratios (and 95% Confidence Intervals) for multimorbidity cluster membership in rural, regional, and metropolitan CRC patients (unadjusted and controlling for age and SES).
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FIGURE 2 | Crude and adjusted (for age and SES) hazard ratios for all – cause mortality over 10 years in metropolitan, inner regional and outer regional and remote
CRC patients. Error bars: 95% CIs.

and future research might benefit from over-representation of
participants in more remote locations. A final consideration
to note when interpreting findings is that the current sample
is particularly reflective of younger, earlier stage colon cancer
patients.

The better health reported by patients in rural communities
was for the most part, not accounted for by differences in age
or SES and therefore may potentially be due to environmental
factors unique to rural living that could be investigated in future
research. Alternatively, the prevalence of other chronic health
conditions in remote areas may appear lower, as residents living
further away from health services are less likely to access medical
attention (45, 46) and therefore less likely to have certain health
conditions identified and diagnosed. Sampling error is another
potential explanation for unexpected findings and replication in
a different sample may be warranted before solid conclusions can
be drawn.

Conclusion
Our findings suggest that very few geographical disparities in
previously diagnosed health conditions are apparent among CRC
patients and those that do exist are largely explained by age
and SES, rather than geographical location itself. In addition,
lower CRC-specific survival rates in inner regional areas do not
appear to be impacted by the limited disparities in previously
diagnosed health conditions that do exist. Public health initiatives
and health services aiming to increase the overall health of CRC
patients and reduce mortality, should be targeted at lower SES
and aging communities and will benefit from addressing lifestyle
changes that impact more than one chronic health condition.

Limitations
The current study was conducted using a large representative
sample of CRC patients, however, some limitations exist. For
example, individual data on SES was not available, meaning the
estimates were based on the status of each local government
area as a whole. This allowed us to draw inferences based
on the average SES of a community but did not allow us
to study individual SES; a method that would result in more
precise estimates. Similarly, information on participant ethnic
identification was not collected and this prevented us from
assessing its role. Finally, our sample of outer regional and
remote participants was small in comparison to other groups.
Although this is representative of the Australian population, it
likely explained their higher variance in outcomes. Equal group
sizes may have led to the emergence of more significant effects
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